Document is current
Any future updates will be listed below
-
Authors
Okonogi, Noriyuki http://orcid.org/0000-0002-9486-1922
Tsuchida, Keisuke http://orcid.org/0000-0002-3548-6472
Ando, Ken http://orcid.org/0000-0003-4011-622X
Ohno, Tatsuya http://orcid.org/0000-0002-6703-3144
Fujiwara, Hiroyuki http://orcid.org/0000-0002-8888-9937
Yoshihara, Kosuke http://orcid.org/0000-0002-2254-3378
Aoki, Takuya
Takano, Hirokuni http://orcid.org/0000-0002-6465-7883
Takekuma, Munetaka http://orcid.org/0000-0002-0807-1845
Okamoto, Aikou http://orcid.org/0000-0002-5079-0464
Nishio, Shin http://orcid.org/0000-0003-2526-630X
-
Clinical Trials BETA
Clinical trials referenced in this document:
umin000017080 at UMIN JapanDocuments that mention this clinical trial
Significance of definitive concurrent chemoradiotherapy for vulvar cancer: a Japanese Gynecologic Oncology Group nationwide survey study
https://doi.org/10.1007/s11604-024-01557-9
- License Information
-
More Information
Article History
Received: 25 November 2023
Accepted: 10 March 2024
First Online: 3 April 2024
Declarations
:
: The author(s) declare that they have no conflict of interest.
: The protocol for this study was approved by the ethics committee of each participating institution (108 Japanese Gynecologic Oncology Group [JGOG] affiliated institutions).
